Alliance A071701 (Brain Metastases) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about the side effects of the study drug and to determine if it will help shrink the cancer by at least 30%.
What is the Condition Being Studied?
Brain Metastases
Who Can Participate in the Study?
Adults who are diagnosed with brain metastases.
Age Group
Adults
What is Involved?
If you choose to join this study, you will:
- Have blood draws
- Have EKG's (a way to measure your heart activity)
- Take 1 of the 3 study drugs that is assigned to your specific cancer
- Keep a pill diary (to help track when you take your pills)
*The 3 types of medication are Abemaciclib, GDC-0084, and Entrectinib
Study Details
Full Title
Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases
Principal Investigator
Medical Oncologist
Protocol Number
IRB:
PRO00104080
NCT:
NCT03994796
Phase
Phase
II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-684-5301